Sastasundar Ventures Ltd (HEALTHX) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sastasundar Ventures Ltd on NSE and BSE, with an AI summary of each filing.
Disclosure of Voting Results of the 37th AGM of the Company held on Monday, 28th September, 2026
Annual General Meeting · 29 Sept 2026, 8:25 pm
Consolidated Scrutinizer''s Report dated September 29, 2026.
Annual General Meeting · 29 Sept 2026, 8:18 pm
Health X Platform Shareholders Approve All Resolutions at 37th AGM Health X Platform Limited announced that shareholders approved all seven resolutions with requisite majority at its 37th AGM held on 28th Sep'26. Total turnout stood at 25,080,158 votes (78.84% of outstanding shares), with over 99.99% voting in favour across all items. Key approvals include the adoption of FY26 financial statements, re-appointment of directors Mrs. Abha Mittal and Mrs. Anjana Dikshit, overall borrowing limits under Section 180(1)(c), creation of asset charges under Section 180(1)(a), and authorisations for inter-corporate loans, guarantees, and investments under Sections 185 and 186.
Brief Proceedings of 37th Annual General Meeting of the Members of the Company held on Monday, 28th September, 2026.
Annual General Meeting · 29 Sept 2026, 1:12 am
Please find attached the disclosure under Reg 30 and Reg 36(1)(b) of SEBI (LODR) Reg, 2015
Others (Uncategorized) · 04 Sept 2026, 8:39 pm
Health X Platform Dispatches 37th AGM Notice and Mandates Physical Security KYC Updation Health X Platform Limited announced that its 37th Annual General Meeting is scheduled for 28th Sep'26 at 3:00 PM IST via video conferencing. Under SEBI LODR Regulation 36(1)(b), the company dispatched web-link details for accessing the FY26 Annual Report and AGM Notice to shareholders without registered email addresses. Additionally, the company issued a reminder pursuant to SEBI regulations requiring physical security holders to complete KYC updates, furnish nomination details to RTA MUFG Intime India, and dematerialize physical holdings to remain eligible for electronic corporate payments.
Please find attached the BRSR Report for FY 2025-26.
Others (Uncategorized) · 04 Sept 2026, 7:44 pm
Health X Platform Limited Releases FY'26 Business Responsibility and Sustainability Report Health X Platform submitted its consolidated FY'26 BRSR, reporting standalone turnover of Rs 75.98 lakh and net worth of Rs 270.86 cr. Traded pharmaceutical and OTC products drove 98.80% of operating revenue. Total workforce expanded to 2,760 permanent employees with an employee turnover rate of 43%. A strategic realignment is underway, including the proposed demerger of financial services and merger of Sastasundar Healthbuddy. ROC West Bengal levied a Rs 8.00 lakh penalty under Section 454 of the Companies Act, which has been fully paid.
Annual Report of the Company for the FY 2025-26
Others (Uncategorized) · 04 Sept 2026, 7:01 pm
Please find attached the Notice of the 37th Annual General Meeting of the Company
Annual General Meeting · 04 Sept 2026, 6:14 pm
Please find attached the intimation regarding the 37th AGM of the Company.
Annual General Meeting · 31 Aug 2026, 6:00 pm
Please find attached the intimation alongwith registration link.
Intimation · 25 Aug 2026, 7:14 pm
Health X Platform to Participate in GIA Healthcare Day Investor Conference Health X Platform Ltd. (HEALTHX) will participate in the GIA Healthcare Day group conference for investors and analysts. The meeting is scheduled for 31st Aug'26, from 2:00 PM to 3:30 PM (IST), at the Jio World Convention Centre in Mumbai. The company stated that no unpublished price-sensitive information will be disclosed during the event. This schedule is subject to potential changes.
Please find attached the disclosure.
Transcript · 18 Aug 2026, 12:25 am
Disclosure under Listing Regulations - Submission of Audio recording of the Earnings Conference call for Q1 FY27
Audio / Video · 12 Aug 2026, 12:30 am
Health X Platform Submits Q1 FY27 Earnings Call Audio Recording Health X Platform (NSE: HEALTHX) submitted the audio recording of its Q1 FY27 earnings conference call held on 11th Aug'26. During the call, senior management discussed the company's performance for the quarter ended 30th Jun'26, provided corporate updates, and conducted an interactive Q&A session with investors and analysts. The recording is available on the company's website. This follows the company's prior intimation of the call schedule on 05th Aug'26, in compliance with SEBI's listing regulations.
Please find attached the Investor Presentation of the Company
Investor Presentation · 08 Aug 2026, 12:56 am
HealthX Q1 FY27: Strong Revenue Growth and Margin Expansion HealthX reported robust performance for the quarter ending Jun-26, with revenue up 47% YoY and 16% QoQ. Gross margin expanded to 7.9%, an increase of 130 bps YoY and 40 bps QoQ, driven by better sourcing and private-label mix. Operating leverage improved, with EBIT margin expanding towards gross margin. The company maintains an asset-light model, with depreciation and finance costs at just 0.7% of revenue. Working capital efficiency remains strong with a net working capital cycle of 28 days.
Please find attached the disclosure
Change in Management · 07 Aug 2026, 11:14 pm
HEALTHX reports Q1FY27 results and re-appoints Independent Director HEALTHX board on 7th Aug'26 approved Q1FY27 results and re-appointed Mrs. Anjana Dikshit as an Independent Director for a second 5-year term, effective 10th Nov'26, subject to shareholder approval. For the quarter ended 30th Jun'26, consolidated revenue was Rs. 44,684.98 lakhs, with a net profit of Rs. 198.67 lakhs, compared to a YoY net profit of Rs. 2,659.21 lakhs. Standalone operations reported a net loss of Rs. 51.43 lakhs on revenue of Rs. 8.00 lakhs for the same period.
Please find attached the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30.06.2026
Financial Result · 07 Aug 2026, 11:03 pm
Health X Q1FY27 Results: Reports Consolidated Profit, Standalone Loss Widens Health X Platform reported consolidated results for Q1 ended 30th Jun'26 with revenue at ₹446.85 Cr and PAT at ₹1.99 Cr, against a loss of ₹12.97 Cr QoQ. The Healthcare Network was the primary revenue driver at ₹411.78 Cr but posted a segment loss of ₹14.87 Cr. Standalone results showed a net loss of ₹51.43 Cr, widening from ₹15.20 Cr QoQ, on revenue of ₹8.00 Cr. The board also re-appointed Mrs. Anjana Dikshit as an Independent Director for a second 5-year term, effective 10th Nov'26.
Please find attached the Outcome of Board meeting held on 7th August, 2026
Outcome · 07 Aug 2026, 10:54 pm
Sastasundar Ventures Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) ■ Revenue: 44,685 (+49.7% YoY | +19.5% QoQ) ■ EBITDA: -837 (Profit to Loss YoY | +66.8% QoQ) ■ EBITDA Margin (%): -1.9 (Profit to Loss YoY | +487 bps QoQ) ■ PAT: 254 (-89.4% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.80 (-89.4% YoY | Loss to Profit QoQ) Sastasundar Ventures Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) Segmental Performance Financial Services ■ Revenue: 656 (-67.0% YoY | Negative to Positive QoQ) ■ EBIT: 557 (-71.4% YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 85.0 (-1305 bps YoY | -2981 bps QoQ) Healthcare Network ■ Revenue: 41,178 (+47.8% YoY | +15.9% QoQ) ■ EBIT: -1,487 (-13.6% YoY | +35.8% QoQ) ■ EBIT Margin (%): -3.6 (+109 bps YoY | +290 bps QoQ) Others ■ Revenue: 2,851 (+25.2% QoQ) ■ EBIT: 54.8 (-42.6% QoQ) ■ EBIT Margin (%): 1.9 (-227 bps QoQ)
Intimation of Schedule of the Earnings Conference Call for Q1 of FY2026-27 and registration Link thereof
Intimation · 11 Aug 2026, 4:00 pm
Health X Platform Limited Schedules Q1 FY27 Earnings Call for 11th August 2026 Health X Platform Limited (HEALTHX) has scheduled its Q1 FY27 earnings conference call for Tue, 11th Aug'26, at 04:00 PM IST. The call will cover financial performance and business updates for the quarter ended 30th Jun'26. Management participation will include Executive Chairman B.L. Mittal and CFO Lokesh Agarwal. The event is hosted by Go India Advisors. The company confirmed only public information will be discussed. Registration is required to receive dial-in details for the investor and analyst event.
Please find the disclosure attached herewith.
Others (Uncategorized) · 04 Aug 2026, 1:14 am
Health X Wins Service Tax Appeal, Averting Rs. 65.19 Lakh Demand Health X Platform has won a service tax appeal initiated on 23-Jun-14 against the Commissioner of Service Tax, Kolkata. In a final order pronounced on 30-Jul-26, the authority deemed the impugned demand of Rs. 65,19,360/- as not sustainable. The demand and any associated penalties have been set aside. The company confirms there is no material financial impact from this litigation, as its appeal was allowed. This resolves a long-pending dispute, removing a potential financial liability.
Health X Platform Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
Intimation · 07 Aug 2026, 5:30 am
Health X Platform Schedules Board Meeting for Q1 FY27 Results Health X Platform (NSE: HEALTHX) will hold a Board of Directors meeting on 7th Aug'26 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th Jun'26. The trading window, closed since 25th Jun'26, will reopen 48 hours after the results are declared.
Disclosure under Reg 30 of SEBI (LODR) - Transcript of Group Conference Call
Transcript · 19 Jun 2026, 6:25 pm
Disclosure under Listing Regulations - Submission of Audio recording of the Group Conference call for Q4 FY26
Audio / Video · 13 Jun 2026, 6:30 pm
Health X Platform Discloses Q4 FY26 Conference Call Recording Health X Platform Ltd. has released the audio recording of its Q4 FY26 investor and analyst conference call, held on 12 Jun'26. Senior management discussed the company's performance for the quarter and year ended 31 Mar'26, followed by a Q&A session. The recording is now accessible on the company's website, as per SEBI regulations. This follows the initial intimation of the call's schedule provided on 02 Jun'26.
Please find attached the Investor Presentation.
Investor Presentation · 11 Jun 2026, 12:51 am
Health X Proposes Composite Scheme to Demerge Businesses & Simplify Structure Health X Platform proposes a composite scheme to demerge its finance business into its subsidiary, Microsec Resources (MRL), and merge its healthcare arm, Sastasundar Healthbuddy (SHBL), into itself. Health X shareholders will receive 1 MRL share for every 3 Health X shares held. Post-scheme, MRL will be listed, creating two distinct listed entities for healthcare and financial services. The public shareholding in the restructured Health X (healthcare business) will increase from 25.93% to 41.57%. The entire process is expected to take 12-14 months.
Please find attached the disclosure
Others (Uncategorized) · 11 Jun 2026, 12:11 am
Health X Platform Board Approves Composite Scheme of Arrangement and Amalgamation The Board of Health X Platform approved a composite scheme of arrangement on 10 Jun'26. The scheme involves a demerger of its financial services undertaking into Microsec Resources (Resulting Co) and the amalgamation of Sastasundar Healthbuddy (Transferor Co) and Innogrow Technologies (Amalgamating Co) with other entities. Shareholders will receive 1 share in the Resulting Co for every 3 Health X shares held. Post-scheme, the promoter holding in the listed entity will dilute from 74.07% to 58.43%, while public shareholding will increase to 41.57%.
Please find the disclosure attached herewith.
Others (Uncategorized) · 10 Jun 2026, 11:56 pm
Health X Platform Board Approves Composite Scheme of Arrangement and Amalgamation Health X Platform's board approved a composite scheme of arrangement and amalgamation on 10th Jun'26. The scheme involves demerging its financial services business into Microsec Resources and amalgamating Sastasundar Healthbuddy and Innogrow Technologies. For the demerger, shareholders will receive 1 share in the resulting company for every 3 shares held in Health X. For the Sastasundar amalgamation, 85,12,168 Health X shares will be issued for 45,75,830 shares. Post-scheme, promoter holding in Health X will dilute from 74.07% to 58.43%.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ravi Kant Sharma & PACs
Acquisition/ Disposal of Shares · 06 Jun 2026, 4:07 pm
Health X Platform Promoter Ravi Kant Sharma Reduces Stake Promoter Ravi Kant Sharma of Health X Platform Ltd (formerly Sastasundar Ventures) sold 2,50,000 shares, equivalent to a 0.79% stake, via a market sale on Jun 3, '26. Following the transaction, his individual holding decreased from 3.14% to 2.35%. The total promoter and promoter group stake was consequently reduced from 74.85% to 74.07%. This disclosure was made under SEBI's substantial acquisition and takeovers regulations. The company's total voting capital remains at 3,18,10,500 equity shares.
Please find attached the disclosure.
Others (Uncategorized) · 05 Jun 2026, 11:11 pm
Health X Promoter Ravi Kant Sharma Sells 2.5 Lakh Shares in Market Transaction Promoter Ravi Kant Sharma sold 2,50,000 equity shares of Health X Platform Ltd for Rs 7.50 crore via a market sale on 03-Jun'26. This transaction reduced his holding from 9,97,393 shares (3.14% of capital) to 7,47,393 shares (2.35%). The company was notified of the sale on 04-Jun'26.